News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Biopharmaceutical Excipients Focused Market Insights 2024-2029: Demand for Novel Excipients in Advancing Biopharmaceutical Development - ResearchAndMarkets.com
Saturday, August 24, 2024The Biopharmaceutical Excipients Market Focused Insights report has been added to ResearchAndMarketscoms offering The Biopharmaceutical Excipients Market was valued at USD billion in and is expected to reach USD billion by rising at a CAGR of
Rafael Holdings and Cyclo Therapeutics Sign Definitive Merger Agreement
Friday, August 23, 2024Rafael Holdings Inc and Cyclo Therapeutics Inc announced that they have entered into a definitive merger agreement to combine the two companies to focus on the development of Trappsol Cyclo for the treatment of NiemannPick Disease Type C
PharmAla Introduces MDMA Clinical Trial Tool for Researchers
Friday, August 23, 2024PharmAla Biotech Holdings Inc a biotechnology company specializing in the research development and manufacturing of LaNeo MDMA and novel derivatives within the MDXX class is excited to announce the release of a new tool designed to assist researchers
Crown Bioscience Collaborates with CTI to Enhance Consulting Services in Oncology Drug Development
Thursday, August 22, 2024Crown Bioscience a global contract research organization CRO and a JSR Life Sciences company today announced a strategic partnership with Clinical Trial Consulting Services CTI a renowned global fullspectrum research service provider to bolster onco...
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
Thursday, August 22, 2024Monopar Therapeutics Inc a clinicalstage radiopharma company focused on developing innovative treatments for cancer patients today announced it has received Human Research Ethics Committee HREC clearance in Australia
Cumulus Oncology and leadXpro Reach Key Milestone in GPR68 Drug Discovery Project
Wednesday, August 21, 2024Cumulus Oncology Europes first biotech company dedicated to oncology innovation has announced significant progress in its GPR drug discovery project in collaboration with leadXpro LXP This achievement has allowed Cumulus to license the small molecule...
Visiox Pharmaceuticals, Inc. Announces Landmark Merger with Ocuvex Therapeutics, Inc.
Tuesday, August 20, 2024Visiox Pharmaceuticals Inc has announced a definitive merger agreement with Ocuvex Therapeutics Inc a privately held ophthalmic pharmaceutical company dedicated to developing and commercializing innovative therapies for glaucoma and other eye disorde...
TEPKINLY® (epcoritamab) Secures Second European Commission Approval for Treating Adults with Relapsed/Refractory Follicular Lymphoma
Tuesday, August 20, 2024Genmab AS announced that the European Commission EC has granted conditional marketing authorization for TEPKINLY epcoritamab as a monotherapy for the treatment of adult patients with relapsed or refractory RR follicular lymphoma FL after two or more...
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
Monday, August 19, 2024Clearmind Medicine Inc a biotech company dedicated to the discovery and development of innovative psychedelicderived therapeutics for addressing significant unmet health needs announced today the submission of a patent application under the internati...
SciSparc Finalizes $3 Million Exclusive Global Out-Licensing Agreement for Its Pain Therapy
Monday, August 19, 2024SciSparc Ltd a specialty clinicalstage pharmaceutical company focused on developing therapies for central nervous system disorders and rare diseases announced the signing of an Exclusive Patent License Agreement with Polyrizon Ltd Polyrizon This agre...
